UK markets open in 2 hours 16 minutes

Galmed Pharmaceuticals Ltd (GPH.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.28000.0000 (0.00%)
At close: 08:10AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
3,121
3,569
12,995
27,220
26,082
-
Selling general and administrative
3,770
3,923
4,656
5,661
4,128
-
Total operating expenses
6,891
7,492
17,651
32,881
30,210
-
Operating income or loss
-6,891
-7,492
-17,651
-32,881
-30,210
-
Total other income/expenses net
-
216
-490
-105
278
-
Income before tax
-6,357
-6,912
-17,866
-32,467
-28,771
-
Income tax expense
-
-
-
-
0
0
Income from continuing operations
-6,357
-6,912
-17,866
-32,467
-28,771
-
Net income
-6,357
-6,912
-17,866
-32,467
-28,771
-
Net income available to common shareholders
-6,357
-6,912
-17,866
-32,467
-28,771
-
Basic EPS
-3.02
-2.50
-10.65
-19.80
-20.25
-
Diluted EPS
-3.02
-2.50
-10.65
-19.80
-20.25
-
Basic average shares
2,832
2,770
1,676
1,640
1,419
-
Diluted average shares
2,832
2,770
1,676
1,640
1,419
-